Acrivon Therapeutics, Inc.

Develops precision cancer therapies by matching patients to drugs using its proteomics platform.

ACRV | NDAQ

Overview

Corporate Details

ISIN(s):: US0048901096
LEI:
Country:: United States of America
Address:: 480 ARSENAL WAY, SUITE 100, 2472 WATERTOWN
Website:: https://acrivon.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Acrivon Therapeutics, Inc. is a clinical-stage biopharmaceutical company specializing in precision oncology. The company leverages its proprietary Acrivon Predictive Precision Proteomics (AP3) platform to develop targeted cancer therapies. The AP3 platform utilizes phosphoproteomics to analyze the biologic drivers of a patient's cancer, enabling the creation of predictive 'OncoSignature' tests. This method is designed to match drug candidates with patients whose tumors are most likely to respond, aiming to improve therapeutic outcomes beyond what is achievable with genomics. Acrivon's pipeline is led by ACR-368, a selective kinase inhibitor in Phase 2 clinical trials for various solid tumors. The company also advances its internally developed programs and seeks strategic partnerships to apply its AP3 platform to co-develop predictive tests for external drug candidates.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Acrivon Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Acrivon Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Acrivon Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
KNT-CT Holdings Co.,Ltd. A travel holding company offering themed tours and corporate travel solutions to boost Japan tourism.	Japan	9726
KoBioLabs, Inc. Develops AI-driven microbiome therapeutics for immune, metabolic, and brain disorders.	South Korea	348150
KOGI CORPORATION Engineering AI & IoT zero-touch hover interfaces for public kiosks and terminals.	Japan	5603
KOLON CORPORATION A holding company for diverse businesses in materials, chemicals, fashion, and life sciences.	South Korea	002020
kt nasmedia Co., Ltd. An integrated digital marketing platform for data-driven online, mobile, and OOH ad solutions.	South Korea	089600
Kubota Pharmaceutical Holdings Co., Ltd. Developing ophthalmic drugs and devices to preserve and restore vision for patients globally.	Japan	4596
Kweather Co., Ltd. Provider of weather data, air quality monitoring, and enterprise climate management solutions.	South Korea	068100
Kymera Therapeutics, Inc. Fintech firm providing data analytics and market intelligence for investment professionals.	United States of America	KYMR
LABCORP HOLDINGS INC. Provides diagnostic lab testing and biopharma drug development services for healthcare clients.	United States of America	LH
LAMAR ADVERTISING CO/NEW A leading OOH advertising REIT with billboards, transit, and airport displays in the US & Canada.	United States of America	LAMR